Baxter International (NYSE:BAX) Releases Q1 2025 Earnings Guidance

Baxter International (NYSE:BAX) updated its first quarter 2025 earnings guidance on Thursday. The company provided EPS guidance of 0.470-0.500 for the period, compared to the consensus EPS estimate of 0.490. The company issued revenue guidance of $3.7 billion-$3.7 billion, compared to the consensus revenue estimate of $2.6 billion. Baxter International also updated its FY 2025 guidance to 2.450-2.550 EPS.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Stifel Nicolaus dropped their price objective on Baxter International from $46.00 to $38.00 and set a “buy” rating for the company in a research note on Monday, November 11th. StockNews.com lowered shares of Baxter International from a “buy” rating to a “hold” rating in a research note on Monday, November 11th. Citigroup reduced their target price on shares of Baxter International from $37.00 to $35.00 and set a “neutral” rating on the stock in a report on Wednesday, December 11th. Finally, Barclays started coverage on Baxter International in a research note on Thursday. They issued an “overweight” rating and a $39.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, Baxter International currently has an average rating of “Hold” and an average target price of $39.40.

Baxter International Price Performance

Shares of BAX stock traded up $2.66 during mid-day trading on Thursday, reaching $33.48. The stock had a trading volume of 5,642,260 shares, compared to its average volume of 4,689,840. The company has a market cap of $17.09 billion, a P/E ratio of 166.95, a price-to-earnings-growth ratio of 9.95 and a beta of 0.61. The company has a current ratio of 1.43, a quick ratio of 1.09 and a debt-to-equity ratio of 1.31. Baxter International has a 12-month low of $28.33 and a 12-month high of $44.01. The business has a 50-day simple moving average of $30.52 and a 200 day simple moving average of $34.15.

Baxter International (NYSE:BAX) last issued its quarterly earnings data on Thursday, February 20th. The medical instruments supplier reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of $0.52 by $0.06. Baxter International had a net margin of 0.77% and a return on equity of 18.30%. On average, sell-side analysts anticipate that Baxter International will post 1.83 earnings per share for the current year.

Baxter International Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Friday, February 28th will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Friday, February 28th. This represents a $0.68 dividend on an annualized basis and a yield of 2.03%. Baxter International’s dividend payout ratio (DPR) is currently 340.02%.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.